Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06943755
PHASE2/PHASE3

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Sponsor: Exelixis

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors.

Official title: A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

440

Start Date

2025-07-21

Completion Date

2029-06-30

Last Updated

2026-07-09

Healthy Volunteers

No

Interventions

DRUG

Zanzalintinib

Administered as specified in the treatment arm.

DRUG

Everolimus

Administered as specified in the treatment arm.

Locations (97)

The University of Alabama at Birmingham

Birmingham, Alabama, United States

Mayo Clinic Hospital

Phoenix, Arizona, United States

The University of Arizona Cancer Center

Tucson, Arizona, United States

Cedars-Sinai Medical Center

Beverly Hills, California, United States

Norris Comprehensive Cancer Center

Los Angeles, California, United States

Stanford Cancer Center

Palo Alto, California, United States

UCLA Health - Santa Monica Cancer Care

Santa Monica, California, United States

Kaiser Permanente Medical Center

Vallejo, California, United States

Georgetown University

Washington D.C., District of Columbia, United States

Mayo Clinic - Florida

Jacksonville, Florida, United States

AdventHealth Orlando

Orlando, Florida, United States

Moffitt Cancer Center

Tampa, Florida, United States

University of Kentucky Markey Cancer Center

Lexington, Kentucky, United States

East Jefferson General Hospital

Metairie, Louisiana, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Henry Ford Caner- Detroit

Detroit, Michigan, United States

The Cancer and Hematology Centers

Grand Rapids, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Siteman Cancer Center

St Louis, Missouri, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

University of New Mexico Comprehensive Cancer Center

Albuquerque, New Mexico, United States

Roswell Park Cancer Institute

Buffalo, New York, United States

Icahan School of Medicine at Mount Sinai

New York, New York, United States

University of Rochester Medical Center

Rochester, New York, United States

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Duke University Medical Center

Durham, North Carolina, United States

Sanford Roger Maris Cancer Center

Fargo, North Dakota, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

The Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Oregon Health and Science University

Portland, Oregon, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center

Pittsburgh, Pennsylvania, United States

University of Tennessee Medical Center

Knoxville, Tennessee, United States

Henry-Joyce Cancer Clinic

Nashville, Tennessee, United States

Texas Oncology- Baylor Charles A. Sammons Cancer Center

Dallas, Texas, United States

Huntsman Cancer Institute, University of Utah

Salt Lake City, Utah, United States

University of Virginia

Charlottesville, Virginia, United States

Virginia Cancer Specialists - Fairfax Office

Fairfax, Virginia, United States

Fred Hutchinson Cancer Center

Seattle, Washington, United States

Froedtert Hospital and the Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Monash Health

Clayton, Australia

Royal Brisbane and Women's Hospital

Herston, Australia

Fiona Stanley Hospital

Murdoch, Australia

GenesisCare North Shore

St Leonards, Australia

The Queen Elizabeth Hospital

Woodville South, Australia

Medical University of Graz

Graz, Austria

Paracelsus Medical University Hospital Salzburg

Salzburg, Austria

Cliniques Universitaires Saint-Luc (UCLouvain)

Woluwe-Saint-Lambert, Belgium

Verspeeten Family Cancer Center - London Health Sciences Centre

London, Canada

The Ottawa Hospital Cancer Center

Ottawa, Canada

Sunnybrook Health Sciences Centre

Toronto, Canada

Humanity and Health Clinical Trial Centre

Hong Kong, China

Prince of Wales Hospital

Hong Kong, China

Queen Mary Hospital

Hong Kong, China

CHU de Montpellier Hôpital Saint Eloi

Montpellier, France

Gustave Roussy

Villejuif, France

Evangelische Lungenklinik

Berlin, Germany

Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg

Marburg, Germany

Universitätsklinikum Tübingen

Tübingen, Germany

University Hospital Würzburg

Würzburg, Germany

Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST s.r.l.

Meldola, Italy

Instituto Europeo di Oncologia

Milan, Italy

Istituto Nazionale Tumori IRCCS - Fondazione Pascale

Naples, Italy

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

Palermo, Italy

Azienda Ospedaliero-Universitaria Policlinico Umberto I

Roma, Italy

Het Netherlands Kanker Institut (NKI)/ Antoni van Leeuwenhoek

Amsterdam, Netherlands

Maastricht Universitair Medisch Centrum

Maastricht, Netherlands

Maxima Medisch Centrum

Veldhoven, Netherlands

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

Gliwice, Poland

Śląskiego Uniwersytet Medyczny w Katowicach

Katowice, Poland

Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwesytecki w Krakowie

Krakow, Poland

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

Warsaw, Poland

FutureMeds Wrocław

Wroclaw, Poland

Pan American Center for Oncology Trials, LLC

San Juan, Puerto Rico

FDI Clinical Resesarch

San Juan, Puerto Rico

Korea University Anam Hospital

Seoul, South Korea

Seoul National University Hospital

Seoul, South Korea

Severence Hospital, Yonsei University Health System

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Hospital Universitario Vall D'Hebron

Barcelona, Spain

Hospital Universitario Ramón y Cajal

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital Universitario La Paz

Madrid, Spain

Hospital General Universitario J.M Morales Meseguer

Murcia, Spain

Hospital Universitario Central de Asturias

Oviedo, Spain

Hospital Universitario Marqués de Valdecilla

Santander, Spain

Hospital Clínico Universitario de Santiago de Compostela

Santiago de Compostela, Spain

Hospital Universitario Vigen Del Rocío

Seville, Spain

Hospital Universitario y Politécnico La Fe

Valencia, Spain

Hospital Universitario Miguel Servet

Zaragoza, Spain

The Clatterbridge Cancer Centre

Liverpool, United Kingdom

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom

King's College Hospital NHS Foundation Trust

London, United Kingdom

Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, United Kingdom

Swansea Bay University Health Board

Swansea, United Kingdom